Plus   Neg

Quest Diagnostics (DGX) Has Fallen To A New Low After Guidance Cut

Quest Diagnostics (DGX) announced after the bell Wednesday that it now expects to report full year adjusted EPS of greater than $6.30. Prior guidance had been for adjusted EPS of $6.53 to $6.60.

Quest Diagnostics gapped open lower Thursday and has dropped further in early trade. Shares are now down 8.10 at $88.82 on above average volume. The stock has fallen to a new low for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT